Literature DB >> 7784432

Inward rectification of neuronal nicotinic acetylcholine receptors investigated by using the homomeric alpha 7 receptor.

I Forster1, D Bertrand.   

Abstract

The strong inward rectification observed in neuronal nicotinic ACh receptors was examined by using alpha-bungarotoxin sensitive, homomeric alpha 7 neuronal nicotinic ACh receptors derived from chick brain. Receptors were expressed in Xenopus laevis oocytes and functionally assessed by the two electrode voltage clamp technique. Site directed mutagenesis of residues thought to line the putative ion pore revealed that negatively charged glutamate residues located at the inner mouth of the channel are essential for rectification. This finding was confirmed both for the active open state and for receptors mutated to conduct in one of the desensitized states. No outward tail relaxations were observed with voltage jumps to depolarizing potentials, suggesting that rectification was not due to intrinsic gating. For the wild type receptor, intracellular injection of CDTA, a chelating agent having a high affinity for Mg2+, reduced rectification in a dose dependent manner, suggesting that rectification originates, in part, from open channel block by internal free Mg2+. These findings support the hypothesis that charged residues at the inner mouth of the pore influence the Mg2+ affinity of the blocking site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784432     DOI: 10.1098/rspb.1995.0071

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  13 in total

Review 1.  The alpha7 nicotinic acetylcholine receptor in neuronal plasticity.

Authors:  R S Broide; F M Leslie
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

2.  A molecular link between inward rectification and calcium permeability of neuronal nicotinic acetylcholine alpha3beta4 and alpha4beta2 receptors.

Authors:  A P Haghighi; E Cooper
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Single channel analysis of conductance and rectification in cation-selective, mutant glycine receptor channels.

Authors:  Andrew J Moorhouse; Angelo Keramidas; Andrey Zaykin; Peter R Schofield; Peter H Barry
Journal:  J Gen Physiol       Date:  2002-05       Impact factor: 4.086

4.  Theoretical studies of the M2 transmembrane segment of the glycine receptor: models of the open pore structure and current-voltage characteristics.

Authors:  Mary Hongying Cheng; Michael Cascio; Rob D Coalson
Journal:  Biophys J       Date:  2005-06-10       Impact factor: 4.033

Review 5.  Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors.

Authors:  Bruce E McKay; Andon N Placzek; John A Dani
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

6.  Neuronal nicotinic acetylcholine receptors are blocked by intracellular spermine in a voltage-dependent manner.

Authors:  A P Haghighi; E Cooper
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

7.  Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Authors:  B Buisson; M Gopalakrishnan; S P Arneric; J P Sullivan; D Bertrand
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

8.  An extracellular scaffolding complex confers unusual rectification upon an ionotropic acetylcholine receptor in C. elegans.

Authors:  Maëlle Jospin; Benjamin Bonneau; Viviane Lainé; Jean-Louis Bessereau
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-12       Impact factor: 12.779

Review 9.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

10.  Changes in cationic selectivity of the nicotinic channel at the rat ganglionic synapse: a role for chloride ions?

Authors:  Oscar Sacchi; Maria Lisa Rossi; Rita Canella; Riccardo Fesce
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.